Koninklijke Vopak N.V. (LON:0O8V)
38.76
-0.34 (-0.87%)
At close: Dec 1, 2025
Koninklijke Vopak Revenue
Koninklijke Vopak had revenue of 321.60M EUR in the quarter ending September 30, 2025, a decrease of -1.05%. This brings the company's revenue in the last twelve months to 1.32B, down -1.69% year-over-year. In the year 2024, Koninklijke Vopak had annual revenue of 1.33B, down -7.73%.
Revenue (ttm)
1.32B EUR
Revenue Growth
-1.69%
P/S Ratio
3.40
Revenue / Employee
257.53K EUR
Employees
5,133
Market Cap
3.92B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.33B | -111.20M | -7.73% |
| Dec 31, 2023 | 1.44B | 55.00M | 3.97% |
| Dec 31, 2022 | 1.38B | 141.90M | 11.43% |
| Dec 31, 2021 | 1.24B | 42.40M | 3.54% |
| Dec 31, 2020 | 1.20B | -61.80M | -4.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 25.65B |